Search Results

Showing results 201 - 210 of 3355.
Sort By: Date ▼

Teva releases generic version of EpiPen for young kids

August 22, 2019

Teva Pharmaceutical Industries on Tuesday released a generic version of Mylan's EpiPen for children who weigh between 33 and 66 pounds, which will be available in the majority of retail pharmacies for $300 for a two-pack.

USPSTF expands recommendation for BRCA mutation screening

August 21, 2019

The U.S. Preventive Services Task Force on Tuesday finalized new recommendations broadening the number of women primary care providers should assess for BRCA gene mutations that increase the risk of breast, ovarian, and other cancers.

For 26 years, doctors couldn't diagnose her disease. Then she found the answer—and helped create a cure.

August 21, 2019

For 26 years, Jasmin Barman-Aksözen experienced inexplicable severe pain when exposed to sunlight—until one day on Google she came across an article about a rare disease called erythropoietic protoporphyria, which a doctor later determined she had. In an editorial published in Medicine Access @ Point of Care, Barman-Aksözen details how she helped develop the cure to her disease and her battle to get it approved.

FDA approves Roche's cancer drug for personalized treatment

August 21, 2019

FDA on Thursday approved Roche's cancer drug designed to target a tumor's genetic driver rather than the tissue where the tumor originated.

E-cigarette makers take FDA to court over 'arbitrary' product review deadline

August 21, 2019

The Vapor Technology Association, an e-cigarette and vaping industry group, and Vapor Stockroom last week filed a lawsuit that argues FDA set an "arbitrary" deadline for e-cigarette makers to submit premarket authorization applications for their devices.

Why CMS is revamping its star ratings (and why hospital groups aren't pleased)

August 20, 2019

CMS on Monday announced the agency in early 2020 will update hospital star ratings using its current methodology, despite pushback from providers who say the methodology is flawed. CMS also said by 2021 it will release a proposed rule aimed at changing the methodology.

Planned Parenthood will no longer participate in Title X program

August 20, 2019

A federal appeals court on Friday again allowed a final rule that bars clinics that receive Title X funding from providing abortions or referring patients to non-emergency abortion care to take effect, prompting Planned Parenthood on Monday to announce plans to officially exit the program.

What it's really like to get dialysis at home

August 20, 2019

The Trump administration wants to shift most dialysis care to patients' homes—a practice that providers say can improve quality of life, but also can present hardships for older patients.

Four more states sue over Trump admin's 'public charge' rule

August 19, 2019

Four more states and Washington, D.C., on Friday filed a lawsuit challenging the Trump administration's final rule that will allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications.

'Rating the raters': How US News, Healthgrades, Leapfrog, and CMS stack up

August 19, 2019

Prominent hospital ratings systems are highly influential, but they also can generate contradictory results that do not always align with clinicians' own assessments, a group of authors write in NEJM Catalyst, highlighting the shortcomings of several major hospital ratings systems.

Results Page: [Previous] ... 21 22 23 24 25  ... [Next]